VAERS reports by lot

GSK Varicella/Shingles lot 2Y9R4: VAERS reports

48 VAERS reports list lot 2Y9R4 as a GSK Varicella/Shingles vaccine, received between 2019-03-10 and 2021-11-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4025%
General / Systemic (non-local)3320%
Musculoskeletal2516%
Neurological2012%
Dermatological (non-injection-site)159%
Cardiac / Cardiovascular74%
Gastrointestinal74%
Allergic / Anaphylactic64%
Thrombotic / Hematological32%
Respiratory32%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Texas4
Wisconsin4
California3
Iowa3
Washington3
Oregon2
Virginia2
South Carolina2
Illinois2
Hawaii2
New Jersey2

Reports by month received

2019-0318
2019-048
2019-055
2019-064
2019-074
2019-082
2019-092
2019-101
2019-111
2020-072
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.